Similar Items: Upregulated BLM and RECQL4 in Osteosarcoma: Association with Poor Prognosis, Immune Cell Infiltration, and Inhibitory Effects of Sphingosine Kinase 1 Inhibitor II/Pilaralisib
- The role of SPP1 in evaluating the prognosis, immune infiltration, and drug sensitivity of hepatocellular carcinoma
- Conservation for the 21st Century, BLM Style
- Recent advances in biomaterials for osteosarcoma treatment
- RIPK3 inhibitor GSK872 targets angiotensin II induced cardiomyocyte hypertrophy by regulating Ca2+/ calmodulin dependent protein kinase II
- Bureau of Land Management Conservation Lands and BLM’s Future
- Structural insights into subtype-specific agonist recognition by sphingosine-1-phosphate receptors